CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Humans Have Kept Evolving New Genes

Humans Have Kept Evolving New Genes

The Necessity of Next-Generation Sequencing

The Necessity of Next-Generation...

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

The Next-Generation Sequencing...

Technologies to have an impact on science this year.

Technologies to have an impact on...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation...

Portuguese Start-Up Kicks Off Genetic Test That Detects Diseases In Babies Using Saliva

Portuguese Start-Up Kicks Off Genetic...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Humans Have Kept Evolving New Genes

Humans Have Kept Evolving New Genes

The Necessity of Next-Generation Sequencing

The Necessity of Next-Generation...

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

The Next-Generation Sequencing...

Technologies to have an impact on science this year.

Technologies to have an impact on...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation...

Portuguese Start-Up Kicks Off Genetic Test That Detects Diseases In Babies Using Saliva

Portuguese Start-Up Kicks Off Genetic...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Life Sciences Review | Thursday, February 24, 2022
Tweet

COVID-19 has had disastrous impacts on cancer patients, resulting in a large number of delayed diagnosis and treatments as a result of COVID-19's restrictions on health systems


FREMONT, CA: In 2019, around 23.6 million new cancer cases and 10 million cancer deaths were reported worldwide, representing a 26.3 percent rise in new cases and a 20.9 percent increase in fatalities when compared to 2010. Furthermore, COVID-19 has had disastrous impacts on cancer patients, resulting in a large number of delayed diagnosis and treatments as a result of COVID-19's restrictions on health systems. As the pandemic subsides, worldwide societies must re-prioritize, ensuring that cancer diagnosis, treatment, and care are of high quality and accessible to all. They believe that the technologies of the fourth industrial revolution (4IR) can help mankind overcome some of the most pressing issues it faces today.


The World Economic Forum is collaborating with worldwide partners to decrease the gap in lung cancer-related premature death and to use innovative technology to improve and revolutionize cancer care in India. Six worldwide pioneers and thought leaders from the science community, public policy, and the corporate sector were asked to share their thoughts for the future of cancer to commemorate World Cancer Day.


 


While it may appear that they are expected to become accustomed to the hidden pandemic known as cancer, which should not be the case. Everyone should join together to confront this ever-increasing global health burden, just as they did with COVID-19. Three lessons must be learnt from the pandemic, first being that science is important. The worldwide cancer burden is increasing, particularly in low- and middle-income countries. The facts are clear; now it's time to plan for the future. One must recognize and treat cancer as early as possible in order to defeat it. Low-dose CT-enabled countrywide lung cancer screening programmes, for example, can help lower mortality rates.


Next is the importance of technology. Digitalization can help patients bridge the gap between rapidly rising medical evidence and a shrinking supply of medical professionals. They have had positive results with telemedicine for COVID-19 patients and AI-based assistants who assist clinicians in making decisions, for example. These skills can be applied to the treatment of cancer patients. Lastly, the team approach must be healthcare. For treating cancer patients, oncologists, surgeons, nurses, radiologists, the medtech and pharma industries and many more are involved. They are altogether on their way to eliminating the fear of cancer by transforming it into a manageable, chronic illness. 


Weekly Brief

loading
TOP VENDORS
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
TOP VENDORS
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
TOP VENDORS
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
TOP VENDORS
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/technologies-that-will-revolutionize-cancer-care-nwid-724.html